You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑋俊生物科技(00660.HK)料將於下周一或之前公布經審核年度業績
阿思達克 11-08 08:47
瑋俊生物科技(00660.HK)公布,山東省於10月繼續爆發新冠疫情,並繼續影響內地子公司的審核程序。在與核數師溝通後,並假定當地政府實施的該等措施可能於臨近10月底或之前大致放寬或解除,核數師還須兩周時間以完成其審核工作。因此,公司估計集團截至今年6月底止18個月的經審核年度業績,將於下周一(14日)或之前公布。 由於需要更多時間以準備就遵循上市規則附錄16的規定載入年報的資料及安排大量印製年報,公司將於11月28日或之前向股東寄發年報。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account